Loading insider details...
Latest Form 4 (Nov 18, 2026): Sale of 135,249 RPRX shares, $9.31M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 18, 2026 | Royalty Pharma plc (RPRX) | Sale | 135,249 | $9.31M |
| Nov 6, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 7,122 | n/a |
| Aug 17, 2026 | Royalty Pharma plc (RPRX) | Sale | 9,230 | $540.8K |
| Aug 7, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 11,002 | n/a |
| May 28, 2026 | Royalty Pharma plc (RPRX) | Sale | 64,399 | $3.48M |
| May 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 24,263 | n/a |
| Apr 30, 2026 | Royalty Pharma plc (RPRX) | Sale | 32,916 | $1.64M |
| Apr 2, 2026 | Royalty Pharma plc (RPRX) | Sale | 1,875 | $90.6K |
| Mar 25, 2026 | Royalty Pharma plc (RPRX) | Sale | 32,916 | $1.50M |
| Mar 4, 2026 | Royalty Pharma plc (RPRX) | Sale | 22,487 | $1.05M |